ASX (AUD): Fisher & Paykel Healthcare Corporation Limited (FPH)
Last Price
29.28
Today's Change
-0.37 (1.24%)
Day's Change
29.20 - 30.05
Trading Volume
469,820
Market Cap
17 Billion
Shares Outstanding
586 Million
Avg Volume
403,819
Avg Price (50 Days)
32.46
Avg Price (200 Days)
32.07
PE Ratio
146.45
EPS
0.20
Earnings Announcement
27-May-2025
Previous Close
29.65
Open
30.05
Day's Range
29.2 - 30.05
Year Range
21.88 - 35.76
Trading Volume
470,024
1 Day Change
5 Day Change
1 Month Change
3 Month Change
6 Month Change
Ytd Change
1 Year Change
3 Year Change
5 Year Change
10 Year Change
Max Change
No result.
Sector: Healthcare - Healthcare
Industry: Medical Instruments & Supplies
Description:
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.